Singapore Institute of Advanced Medicine Holdings Ltd
Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist. The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am. Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases. SAM has strategic collaborations with public and private institutions for research and clinical work. SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi
Comments
Do you know what's the NAV of this trust ? Tks
broker for kayhian and ocbc tell me institutional demand v strong.
I went to do a valuation myself using Fortune REIT and CRCT mixture as 0.76 of asset of MGCCT is Hong Kong Mall and 0.24 is China office.
Apparently, if you take Fortune REIT book price of 0.766 x 0.76 + CRCT book price of 1.387 x 0.24, you should get a book price of MGCCT of only 0.912.
Thus, this means price will be 0.848 (There is this nagging risk that I cannot minus off). Together with its short lease life.
But if we do the same for yield, we should get MGCCT price of 1.06 trading at yield 4.93%
Thus, we can expect the stock to trade at 0.85 to 1.06.
No stagging possibility.....
This one really fast.
My money came back into my UOB a/c already at 2.10 pm.
Is it safe to assume I am alloted 12 lots ?